General Information of the Compound
| Compound ID |
CP0931095
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R)-N5-(5-Bromo-thiazol-2-yl)-(6R)-N6-(piperidin-4-yl-methyl)-(4S,7R)-[4,7-ethenylene-spiro[2.4]heptane]-5,6-dicarboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H25BrN4O2S
|
||||||||||||||||||
| Molecular Weight |
465.417
|
||||||||||||||||||
| Canonical SMILES |
O=C(NCC1CCNCC1)[C@H]1[C@H](C(=O)Nc2ncc(Br)s2)[C@@H]2C=C[C@H]1C21CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H25BrN4O2S/c21-14-10-24-19(28-14)25-18(27)16-13-2-1-12(20(13)5-6-20)15(16)17(26)23-9-11-3-7-22-8-4-11/h1-2,10-13,15-16,22H,3-9H2,(H,23,26)(H,24,25,27)/t12-,13+,15-,16-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZVXCRIURVJFTTN-OCVGTWLNSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00605, FML2_HUMAN
Protein ID: PT02590, N-formyl peptide receptor 2